Catalyst

Slingshot members are tracking this event:

Sarilumab BLA submission expected first quarter of 2017

Source Link:
http://seekingalpha.com/article/4035911-regeneron-pharmaceuticals-regn-presents-35th-annual-j-p-morgan-healthcare-conference

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
REGN Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Apr 28, 2017
Occurred Source:
http://files.shareholder.com/downloads/REGN/4396649916x0x939804/A7360008-FF1E-4290-AEA0-E539AAF50E01/REGN_News_2017_4_28_General_Releases.pdf
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Sarilumab, Bla Submission, Biologics License Application
About Us
Media Center
Connect with Us
© 2025 Slingshot Insights. All rights reserved.